Skip to main content

Closed

CRNX: Crinetics Pharmaceuticals, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

99thpctl

Volume

0.50×avg

Market Cap

8.84BUSD

P/E Ratio

-16.2TTM

Div Yield

-ann

Crinetics Pharmaceuticals, Inc.

CRNXNASDAQ Global Select·USD·Closed

Crinetics Pharmaceuticals, Inc.

CRNXNASDAQ·USD·Closed

$83.52

−0.13%

$83.52

−$0.11 (0.13%)

52W Range

99thpctl

Volume

0.50×avg

Mkt Cap

8.84BUSD

P/E

-16.2TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings